BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:9MW1911 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of 9MW1911\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07292714-1276@assetmemo.bio
DTSTAMP:20261121T005450Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:9MW1911: Phase 2 readout est. (NCT07292714)
DESCRIPTION:9MW1911\, phase 2\, Chronic Obstructive Pulmonary Disease.\nStu
 dy: A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmo
 nary Disease (COPD)\nEstimated primary completion: December 2027. This is 
 a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can 
 move.\nDrug page: https://assetmemo.bio/drug/9mw1911#upcoming-events\nRegi
 stry record: https://clinicaltrials.gov/study/NCT07292714
URL:https://assetmemo.bio/drug/9mw1911#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
